World's Best Scientists 2026 revealed!
Matthias Cavassini

Matthias Cavassini

D-Index & Metrics

Medicine

D-Index
85
Citations
31200
World Ranking
14481
National Ranking
207

Matthias Cavassini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Matthias Cavassini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 532 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Matthias Cavassini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Matthias Cavassini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Matthias Cavassini is affiliated with the University of Lausanne in Switzerland. Their research primarily focuses on medicine, with a strong specialization in infectious diseases. Within this domain, their work spans various subfields including infectious diseases, virology, emergency medicine, epidemiology, and surgery.

The scientist's research themes concentrate on HIV and related health issues. Their main topics of study include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • HIV, Drug Use, Sexual Risk
  • Hepatitis C virus research
  • Pneumocystis jirovecii pneumonia detection and treatment

Matthias Cavassini has a prolific publication record, with notable recent papers such as:

  • "Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)", 2021, International Journal of Epidemiology
  • "Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV", 2021, Annals of Internal Medicine
  • "Long-acting antiretrovirals: a new era for the management and prevention of HIV infection", 2021, Journal of Antimicrobial Chemotherapy
  • "A highly virulent variant of HIV-1 circulating in the Netherlands", 2022, Science
  • "Evolocumab in HIV-Infected Patients With Dyslipidemia", 2020, Journal of the American College of Cardiology

The venues in which Matthias Cavassini frequently publishes include:

  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases
  • Revue Médicale Suisse
  • Journal of Antimicrobial Chemotherapy

Collaborative work forms a significant part of their research practice. Their frequent co-authors include:

  • Enos Bernasconi
  • Alexandra Calmy
  • Huldrych F. Günthard
  • Roger D. Kouyos
  • Dominique L. Braun

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

    Adam Trickey;Margaret T May;Jorg-Janne Vehreschild;Niels Obel

  • Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.

    Samanta Simioni;Matthias Cavassini;Jean Marie Annoni;Aline Rimbault Abraham

  • Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

    Barbara Hasse;Bruno Ledergerber;Hansjakob Furrer;Manuel Battegay

  • PD-1 + and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals

    Riddhima Banga;Francesco Andrea Procopio;Alessandra Noto;Georgios Pollakis

  • Dominant TNF-α + Mycobacterium tuberculosis –specific CD4 + T cell responses discriminate between latent infection and active disease

    Alexandre Harari;Virginie Rozot;Felicitas Bellutti Enders;Matthieu Perreau

  • Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

    R Weber;M Ruppik;M Rickenbach;A Spoerri

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

    Anthony Mills;Jose R. Arribas;Jaime Andrade-Villanueva;Giovanni DiPerri

  • Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

    S. Franceschi;M. Lise;G. M. Clifford;M. Rickenbach

  • Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study

    Bruno Ledergerber;Hansjakob Furrer;Martin Rickenbach;Roger Lehmann

  • Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals

    M Rotger;H Tegude;S Colombo;M Cavassini

  • CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial

    Jintanat Ananworanich;Angèle Gayet-Ageron;Michelle Le Braz;Wisit Prasithsirikul

  • Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.

    Frank A Post;Graeme J Moyle;Hans Jürgen Stellbrink;Pere Domingo

  • Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

    Aysel Gueler;André Moser;Alexandra Calmy;Huldrych F. Günthard

  • Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.

    Marie Helleberg;Margaret T. May;Suzanne M. Ingle;Francois Dabis

  • Evaluation of MRSA-Screen, a Simple Anti-PBP 2a Slide Latex Agglutination Kit, for Rapid Detection of Methicillin Resistance in Staphylococcus aureus

    Matthias Cavassini;Aline Wenger;Katia Jaton;Dominique S. Blanc

  • Minority Quasispecies of Drug-Resistant HIV-1 That Lead to Early Therapy Failure in Treatment-Naive and -Adherent Patients

    Karin J. Metzner;Stefano G. Giulieri;Stefanie A. Knoepfel;Pia Rauch

  • Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

    Jean Michel Molina;Bonaventura Clotet;Jan van Lunzen;Adriano Lazzarin

  • Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.

    Tracy R Glass;Sabina De Geest;Rainer Weber;Pietro L Vernazza

Frequent Co-Authors

Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Hansjakob Furrer
Hansjakob Furrer University of Bern
Manuel Battegay
Manuel Battegay University Hospital of Basel
Alexandra Calmy
Alexandra Calmy University of Geneva
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Sabine Yerly
Sabine Yerly University of Geneva
Andri Rauch
Andri Rauch University of Bern
Bruno Ledergerber
Bruno Ledergerber University of Zurich
Rainer Weber
Rainer Weber University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing your career in medicine or healthcare doesn’t always mean spending years on campus. Today, numerous online dnp programs without dissertation are available, allowing experienced nurses to earn a terminal degree with more flexibility and fewer research requirements.

If you’re at the start of your nursing career, a lpn accelerated program can help you qualify for entry-level nursing roles faster through condensed coursework and online study options.

For nurses looking to specialize in mental health, the shortest post master's pmhnp online programs offer a fast-track to advanced certification, blending flexibility with a quick route to becoming a Psychiatric Mental Health Nurse Practitioner.

Not all medical careers require a clinical license—those interested in the administrative side may pursue a bachelors in healthcare administration. These online programs prepare graduates for vital management and leadership roles within the healthcare system.

Whether you are focused on direct patient care or the crucial support roles behind the scenes, these diverse online pathways provide opportunities to accelerate your goals in the booming healthcare sector.

Best Scientists Citing Matthias Cavassini

Trending Scientists

Recently Published Articles